Gen Pharmaceuticals
Focus: Gen Pharmaceuticals is a Turkish-based generic and branded small-molecule pharmaceutical company focused on cardiovascular, neurology, musculoskeletal, immunology, and metabolic disease treatments. The company operates primarily in mature, off-patent markets with significant revenue concentration in a single blockbuster generic.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Gen Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Gen Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
1 imminent
DAPAGLIFLOZIN
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$129M Part DDeclining
Post-LOE
Flagship calcium-channel blocker generating 50% of company revenue; mature generic with facing steady erosion as patent cliff deepens.
Help build intelligence for Gen Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.